Skip navigation

Discover What’s Next in Access and Prescription Assistance

March 16-17, 2017
  • Baltimore, MD

For the past 17 years, CBI has been devoted to providing the longest standing, most meaningful and largest forum for stakeholders dedicated to prescription drug coverage, financial support and access to care. As pricing pressures, politics, regulatory scrutiny and “underinsurance” converge, PAP 2017 analyzes the legalities, intricacies and best practices for these vital programs at a time of unprecedented need. Join this important event where we pave a new path forward for meaningful and effective patient assistance and co-pay models.

Lighting the Path Forward and Navigating Complex Change
— Benefit from In-Depth Discussion on Topics Including:

  • The impact of new administration on patient assistance
  • Trends in patient support and advocacy and patient-centric approaches to assistance
  • Evolving models of assistance for the uninsured and underinsured community
  • Marketplace trends impacting patient access, affordability and adherence
  • Legislative and regulatory factors influencing advocacy and access
  • New waves of patients and evolving models of assistance
  • Reimbursement support program optimization with electronic benefit verification
  • Optimizing PAP, co-pay and hub programs to allow greater patient access
  • Trends and insights in co-pay program assistance and utilization
  • Patient-centric considerations for hub services and reimbursement support
  • Payer approaches to specialty drug utilization management
A SPECIAL THANK YOU TO THE 2017 ADVISORY BOARD The below patient access visionaries lent their insights and expertise to drive an innovative agenda featuring powerful programming and compelling content on the timeliest matters:

KEVIN NORRETT
Vice President,
Market Access and
Commercial Development
ZS Pharma, Inc

CATHERINE BLANSFIELD
Vice President,
Access and
Outcomes Services
NORD

BILL GOODSON
Director,
Market Access and
Reimbursement Services
Eisai, Inc.

ART WOOD
Senior Vice President,
Marketing and Development
Patient Services Incorporated (PSI)

EMILY GIBB
Senior Director,
Public Policy and
Patient Assistance
GSK

Previous Attendee Aclaim...

YOUR KEY POINTS OF CONTACT:

March 16-17, 2017 Renaissance Harborplace Baltimore, MD

PAP 2017 — 18th Patient Assistance & Access Programs

Discover What’s Next in Access and Prescription Assistance

For the past 17 years, CBI has been devoted to providing the longest standing, most meaningful and largest forum for stakeholders dedicated to prescription drug coverage, financial support and access to care. As pricing pressures, politics, regulatory scrutiny and “underinsurance” converge, PAP 2017 analyzes the legalities, intricacies and best practices for these vital programs at a time of unprecedented need. Join this important event where we pave a new path forward for meaningful and effective patient assistance and co-pay models.

Lighting the Path Forward and Navigating Complex Change
— Benefit from In-Depth Discussion on Topics Including:

  • The impact of new administration on patient assistance
  • Trends in patient support and advocacy and patient-centric approaches to assistance
  • Evolving models of assistance for the uninsured and underinsured community
  • Marketplace trends impacting patient access, affordability and adherence
  • Legislative and regulatory factors influencing advocacy and access
  • New waves of patients and evolving models of assistance
  • Reimbursement support program optimization with electronic benefit verification
  • Optimizing PAP, co-pay and hub programs to allow greater patient access
  • Trends and insights in co-pay program assistance and utilization
  • Patient-centric considerations for hub services and reimbursement support
  • Payer approaches to specialty drug utilization management
A SPECIAL THANK YOU TO THE 2017 ADVISORY BOARD The below patient access visionaries lent their insights and expertise to drive an innovative agenda featuring powerful programming and compelling content on the timeliest matters:

KEVIN NORRETT
Vice President,
Market Access and
Commercial Development
ZS Pharma, Inc

CATHERINE BLANSFIELD
Vice President,
Access and
Outcomes Services
NORD

BILL GOODSON
Director,
Market Access and
Reimbursement Services
Eisai, Inc.

ART WOOD
Senior Vice President,
Marketing and Development
Patient Services Incorporated (PSI)

EMILY GIBB
Senior Director,
Public Policy and
Patient Assistance
GSK

Previous Attendee Aclaim...

YOUR KEY POINTS OF CONTACT:

March 16-17, 2017 Renaissance Harborplace Baltimore, MD